ArticlePloS one2015

The novel tubulin polymerization inhibitor MHPT exhibits selective anti-tumor activity against rhabdomyosarcoma in vitro and in vivo.

Yan Mu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.